MENU
BCLI
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Brainstorm Cell Therapeutics (BCLI) Ownership - Who owns Brainstorm Cell Therapeutics?

Profile

Industry
Computer Peripherals
Address
1325 Avenue of Americas
Phone
+1 201 488-0460
Employees
29
Web
https://www.brainstorm-cell.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.36M
P/E Ratio
N/A
Total Cash
3.47M
Projected Growth
N/A
Total Debt
962K
Revenue
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BCLI
Capitalization
18.4M
P/E Ratio
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash
3.47M
Total Cash/Share
0.65
Total Debt
962K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-3.53M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
0.50
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
10.00
Revenue To Assets
-223.03
Shares Held By Institutions
4.99M
Shares Outstanding - Current
5.32M
Total Liabilities
9.21M
Total Volume MTD
N/A
Value
-1
Gain YTD
-46.764
View a ticker or compare two or three
BCLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company, which develops innovative adult stem cell therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
1325 Avenue of Americas
Phone
+1 201 488-0460
Employees
29
Web
https://www.brainstorm-cell.com